+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level



Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level



Annals of the Rheumatic Diseases 69(2): 450-457



Achieving joint regeneration in rheumatoid arthritis (RA) represents a future challenge. Autologous synovial mesenchymal stem cells (MSCs) could be therapeutically exploited. However, the inflammatory milieu in the RA synovium could adversely affect endogenous MSC function. To test this hypothesis, the frequency and multipotency of RA synovial MSCs was evaluated in relation to existing synovial inflammation. Synovial inflammation was measured using the arthroscopic visual analogue score (VAS) and further validated using immunohistochemistry and flow cytometry. Highly proliferative clonogenic in vivo MSCs were enumerated following fluorescence-activated cell sorting and expansion for 20 population doublings. MSC multipotency was quantified following standard in vitro culture expansion and trilineage differentiation assays. Real-time PCR, flow cytometry and ELISA were used to evaluate pro- and anti-chondrogenic molecules in standard polyclonal synovial MSCs. The arthroscopic VAS significantly correlated with synovial macrophage infiltration. In RA, synovial MSC chondrogenesis was inhibited in direct relation to VAS (r = -0.777, p<0.05) and reduced compared with control osteoarthritis (OA)-MSCs (p<0.05). In vivo, MSCs resided in the synovial fibroblastic/stromal fraction (CD45(-)CD31(-)) and were reduced in frequency in relation to VAS (r = -0.695, p<0.05). In RA-MSCs, CD44 levels correlated negatively with inflammation and positively with chondrogenesis (r = -0.830 and r = 0.865, respectively). Cytokine production and Sox9 expression was similar in RA-MSCs and OA-MSCs. There is a negative relationship between synovial MSC chondrogenic and clonogenic capacities and the magnitude of synovitis in RA. Effective suppression of joint inflammation is therefore necessary for the development of autologous MSC treatments aimed at cartilage regeneration in RA.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054333830

Download citation: RISBibTeXText

PMID: 19346219

DOI: 10.1136/ard.2008.106435


Related references

Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. Arthritis and Rheumatism 58(6): 1731-1740, 2008

Autologous synovial fluid enhances migration of mesenchymal stem cells from synovium of osteoarthritis patients in tissue culture system. Journal of Orthopaedic Research 26(10): 1413-1418, 2008

Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis. Arthritis Research and Therapy 15(5): R169, 2013

COMPARISON OF TUMOR NECROSIS FACTOR α INDUCED APOPTOSIS BETWEEN SYNOVIUM-DERIVED MESENCHYMAL STEM CELLS AND BONE MARROW MESENCHYMAL STEM CELLS. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 30(4): 473-478, 2016

Synovial inflammation reduces chondrogenic potential of resident mesenchymal stem cells. 2006

Mouse synovial mesenchymal stem cells increase in yield with knee inflammation. Journal of Orthopaedic Research 33(2): 246-253, 2015

Mesenchymal Stem Cells Obtained from Synovial Fluid Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells on a Matrigel Coating Exhibited Enhanced Proliferation and Differentiation Potential. Plos one 10(12): E0144226, 2015

Higher chondrogenic potential of fibrous synovium- and adipose synovium-derived cells compared with subcutaneous fat-derived cells: distinguishing properties of mesenchymal stem cells in humans. Arthritis and Rheumatism 54(3): 843-853, 2006

Mechanism by which prolactin produced by synovial cells and synovium-infiltrating T lymphocytes augments synovial cell function in patients with rheumatoid arthritis. Arthritis & Rheumatism 41(9 Suppl. ): S277, 1998

Identification of mesenchymal stem cells derived from rheumatoid arthritis synovial fluid and their regulatory effect on osteoblast formation. Zhongguo Shi Yan Xue Ye Xue Za Zhi 17(4): 977-980, 2009

Lysophosphatidic acid mediates migration of human mesenchymal stem cells stimulated by synovial fluid of patients with rheumatoid arthritis. Biochimica et Biophysica Acta 1801(1): 23-30, 2010

Serum and synovial fluid levels of YKL-40 in relation to synovial inflammation in patients with rheumatoid arthritis and osteoarthritis. Arthritis & Rheumatism 40(9 Suppl. ): S248, 1997

Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts. Arthritis Research and Therapy 9(6): 223, 2007

Functional assessment of Fanconis anemia hematopoietic stem cells and mesenchymal stem cells HSCs display loss of function. Blood 94(10 Suppl. 1 Part 1): 411a, 1999

Next Generation Mesenchymal Stem Cell (MSC)-Based Cartilage Repair Using Scaffold-Free Tissue Engineered Constructs Generated with Synovial Mesenchymal Stem Cells. Cartilage 6(2 Suppl): 13s-29s, 2015